| 2026-08-21 | 8-K | Form 8-K, Item 1.01 |
| 2026-08-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-27 | Press release | The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call |
| 2026-07-27 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-07 | 8-K | Form 8-K, Item 1.01 |
| 2026-06-18 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-22 | 8-K | Form 8-K, Item 1.05 |
| 2026-05-07 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-07 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-30 | Proxy | Definitive proxy statement |
| 2026-03-13 | 8-K | Form 8-K, Item 7.01 |
| 2026-03-12 | 8-K | Form 8-K, Item 2.02 results |
| 2026-03-12 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-23 | 8-K | Form 8-K, Item 5.02 |
| 2026-01-12 | 8-K | Form 8-K, Item 2.02 results |
| 2026-01-07 | 8-K | Form 8-K, Item 5.02 |
| 2025-12-01 | 8-K | Form 8-K, Item 5.02 |
| 2025-11-14 | 8-K | Form 8-K, Item 7.01 |
| 2025-11-13 | 8-K | Form 8-K, Item 2.02 results |
| 2025-11-13 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-11-06 | 8-K | Form 8-K, Item 7.01 |
| 2025-08-13 | 8-K | Form 8-K, Item 5.02 |
| 2025-08-13 | 8-K | Form 8-K, Item 2.02 results |
| 2025-08-13 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2025-05-19 | 8-K | Form 8-K, Item 7.01 |
| 2025-05-14 | 8-K | Form 8-K, Item 2.02 results |
| 2025-05-14 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2025-05-08 | 8-K | Form 8-K, Item 5.07 |
| 2025-05-07 | 8-K | Form 8-K, Item 5.02 |
| 2025-04-11 | 8-K | Form 8-K, Item 8.01 |
| 2025-03-27 | 8-K | Form 8-K, Item 1.01 |
| 2025-03-27 | Proxy | Definitive proxy statement |
| 2025-03-26 | 10-K | Annual report on Form 10-K, FY24 |
| 2025-03-25 | 8-K | Form 8-K, Item 1.01 |
| 2025-03-24 | 8-K | Form 8-K, Item 2.02 results |
| 2025-03-24 | 8-K | Form 8-K, Item 7.01 |
| 2025-02-26 | 8-K | Form 8-K, Item 1.01 |
| 2024-12-19 | 8-K | Form 8-K, Item 3.01 |
| 2024-11-13 | 8-K | Form 8-K, Item 2.02 results |